![Eric Bischoff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Eric Bischoff worked as a Senior Vice President of Development & Operations at Rayzebio, Inc. and as a Vice President of Development & Operations at Metacrine, Inc. He also worked as a Senior Director of Operations at Seragon Pharmaceuticals, Inc. and as a Director of Operations at Aragon Pharmaceuticals, Inc. Bischoff completed his undergraduate degree at the University of California San Diego.
Precedenti posizioni note di Eric Bischoff
Società | Posizione | Fine |
---|---|---|
RAYZEBIO, INC. | Direttore operativo | 26/02/2024 |
METACRINE, INC. | Direttore operativo | 01/11/2020 |
Seragon Pharmaceuticals, Inc.
![]() Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Direttore operativo | - |
Aragon Pharmaceuticals, Inc.
![]() Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Direttore operativo | - |
Formazione di Eric Bischoff
University of California San Diego | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
METACRINE, INC. | Health Technology |
RAYZEBIO, INC. | Health Technology |
Aziende private | 2 |
---|---|
Aragon Pharmaceuticals, Inc.
![]() Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Health Technology |
Seragon Pharmaceuticals, Inc.
![]() Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Eric Bischoff